Market Overview:
The global riluzole tablet market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurological disorders, rising geriatric population, and growing demand for novel therapies. Based on type, the global riluzole tablet market can be segmented into film-coated and without film-coated tablets. The without film-coated tablets segment is expected to grow at a higher CAGR during the forecast period as compared to the other type segments. This can be attributed to their lower manufacturing cost and easy availability in developing countries. Based on application, the global riluzole tablet market can be segmented into hospital and pharmacy settings. The hospital setting segment is expected to grow at a higher CAGR during the forecast period as compared to other application segments owing high prevalence of neurological disorders such as ALS (amyotrophic lateral sclerosis) in this setting across all regions studied herein.
Product Definition:
Riluzole Tablet is used for the treatment of amyotrophic lateral sclerosis (ALS). It helps to prolong life in people with ALS.
With Film-coated:
With film-coated, it’s refers to the layer of aluminum hydroxide that is formed on the surface of riluzole tablets. The growth factor in riluzole tablet market is defined as the rate at which new companies are seeking to commercialize products with a similar mechanism of action as that of riluzole and are able to obtain marketing authorization from regulatory bodies such as FDA and EMA.
Without Film-coated:
Film-coated riluzole tablets are used in the treatment of multiple system atrophy (MSA), also known as Lou Gehrig's disease. The drug was first approved by the U.S. FDA in 1995 for use as a second line of treatment for patients who failed to respond to interferon therapy and were expected to have a poor prognosis.
Application Insights:
The global riluzole tablet market is segmented by application into hospital and pharmacy. The hospital segment dominated the overall industry in 2017, accounting for over 60% of the total revenue share. This high share is attributable to growing incidence of COVID-19 pandemic across the globe that has led to increased demand for medicines with rapid acting action such as riluzole.
Rise in healthcare spending due to increasing prevalence of chronic diseases such as cancer and cardiovascular diseases along with a aging population across various regions including Asia Pacific and Middle East & Africa is expected to drive growth over the forecast period.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market with a CAGR of XX% from 2018 to 2030 owing to increasing product demand in countries, such as China and India. In addition, rising healthcare expenditure by the government coupled with an increase in R&D activities for new drug development will drive growth over the forecast period.
North America held a significant share of global riluzole tablet market due to high disposable income and improved access to healthcare facilities along with rising awareness about cancer treatment options among individuals living in U.S., Canada, and Mexico.
Growth Factors:
- Increasing prevalence of neurological disorders: The global prevalence of neurological disorders is increasing rapidly. This is mainly due to the aging population and the increase in lifestyle-related diseases. This is expected to drive the demand for riluzole tablets in the coming years.
- Growing awareness about riluzole tablets: There is a growing awareness among people about the benefits of riluzole tablets in treating various neurological disorders. This is expected to drive demand for these drugs in the coming years.
- Rising incidence of neurodegenerative diseases: The incidence of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease is rising rapidly across the world due to changing lifestyles and aging population. This is expected to create a high demand for riluzole tablets in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Riluzole Tablet Market Research Report
By Type
With Film-coated, Without Film-coated
By Application
Hospital, Pharmacy
By Companies
Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma, Italfarmaco, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Riluzole Tablet Market Report Segments:
The global Riluzole Tablet market is segmented on the basis of:
Types
With Film-coated, Without Film-coated
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Mylan Pharma
- Apotex
- Glemark Generics
- Covis Pharma
- Sun Pharma
- Lunan Pharma
- Italfarmaco
- Sanofi
Highlights of The Riluzole Tablet Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With Film-coated
- Without Film-coated
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Riluzole Tablet Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Riluzole is a medication used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. It works by slowing the progression of the disease. Riluzole is usually given in combination with other medications, such as a steroid, to help improve symptoms.
Some of the key players operating in the riluzole tablet market are Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma, Italfarmaco, Sanofi.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Riluzole Tablet Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Riluzole Tablet Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Riluzole Tablet Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Riluzole Tablet Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Riluzole Tablet Market Size & Forecast, 2018-2028
4.5.1 Riluzole Tablet Market Size and Y-o-Y Growth
4.5.2 Riluzole Tablet Market Absolute $ Opportunity
Chapter 5 Global Riluzole Tablet Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Riluzole Tablet Market Size Forecast by Type
5.2.1 With Film-coated
5.2.2 Without Film-coated
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Riluzole Tablet Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Riluzole Tablet Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Riluzole Tablet Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Riluzole Tablet Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Riluzole Tablet Analysis and Forecast
9.1 Introduction
9.2 North America Riluzole Tablet Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Riluzole Tablet Market Size Forecast by Type
9.6.1 With Film-coated
9.6.2 Without Film-coated
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Riluzole Tablet Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Riluzole Tablet Analysis and Forecast
10.1 Introduction
10.2 Europe Riluzole Tablet Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Riluzole Tablet Market Size Forecast by Type
10.6.1 With Film-coated
10.6.2 Without Film-coated
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Riluzole Tablet Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Riluzole Tablet Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Riluzole Tablet Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Riluzole Tablet Market Size Forecast by Type
11.6.1 With Film-coated
11.6.2 Without Film-coated
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Riluzole Tablet Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Riluzole Tablet Analysis and Forecast
12.1 Introduction
12.2 Latin America Riluzole Tablet Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Riluzole Tablet Market Size Forecast by Type
12.6.1 With Film-coated
12.6.2 Without Film-coated
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Riluzole Tablet Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Riluzole Tablet Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Riluzole Tablet Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Riluzole Tablet Market Size Forecast by Type
13.6.1 With Film-coated
13.6.2 Without Film-coated
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Riluzole Tablet Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Riluzole Tablet Market: Competitive Dashboard
14.2 Global Riluzole Tablet Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Mylan Pharma
14.3.3 Apotex
14.3.4 Glemark Generics
14.3.5 Covis Pharma
14.3.6 Sun Pharma
14.3.7 Lunan Pharma
14.3.8 Italfarmaco
14.3.9 Sanofi
